[ARAY] Accuray Incorporated

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization: 432.92 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 4.6 Change: -0.15 (-3.16%)
Ext. hours: Change: 0 (0%)

chart ARAY

Refresh chart

Strongest Trends Summary For ARAY

ARAY is in the long-term down -70% below S&P in 7 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors in Europe, Japan and rest of Asia, South America, and internationally to hospitals and stand-alone treatment facilit

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding80.92 M EPS-0.38 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -4.4% Sales Growth - Q/Q-0.65% P/E-11.45
P/E To EPS Growth P/S1.14 P/BV5.66 Price/Cash Per Share2.84
Price/Free Cash Flow-37.37 ROA-9.58% ROE-58.08% ROI-15.43%
Current Ratio2.1 Quick Ratio1.44 Long Term Debt/Equity1.1 Debt Ratio2.17
Gross Margin37.73% Operating Margin-5.88% Net Profit Margin-11.69% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.71 M Cash From Investing Activities18.63 M Cash From Operating Activities-12.6 M Gross Profit38.66 M
Net Profit-2.97 M Operating Profit1.17 M Total Assets463.66 M Total Current Assets347.97 M
Total Current Liabilities165.79 M Total Debt200.99 M Total Liabilities387.18 M Total Revenue97.52 M
Technical Data
High 52 week5.9 Low 52 week3.31 Last close3.88 Last change-1.52%
RSI70 Average true range0.21 Beta1.14 Volume646.59 K
Simple moving average 20 days8.29% Simple moving average 50 days-4.09% Simple moving average 200 days-7.49%
Performance Data
Performance Week3.74% Performance Month2.65% Performance Quart5.15% Performance Half-3%
Performance Year-15.65% Performance Year-to-date13.78% Volatility daily2.87% Volatility weekly6.43%
Volatility monthly13.17% Volatility yearly45.62% Relative Volume806.1% Average Volume925.94 K
New High New Low-1.08%

News

2019-04-16 10:31:02 | Accuray ARAY May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2019-04-11 08:33:12 | Here's Why Investors Should Retain Accuray ARAY Stock Now

2019-04-09 09:41:01 | Varian Medical's VAR ProBeam Installed in China's HIMC

2019-04-07 09:16:00 | Better Buy: Intuitive Surgical vs. Accuray

2019-04-04 15:42:03 | When Can We Expect A Profit From Accuray Incorporated NASDAQ:ARAY?

2019-04-02 07:30:00 | Accuray to Report Fiscal 2019 Third Quarter Financial Results on April 23, 2019

2019-03-27 08:34:12 | Varian Medical VAR Collaborates With Korea-Based Hospital

2019-03-18 08:58:12 | Intuitive Surgical da Vinci SP Gets FDA Nod, Prospects Bright

2019-03-12 08:48:12 | Varian & Tata Trust Tie Up to Boost Radiotherapy in India

2019-02-22 07:30:00 | Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with Localized Prostate Cancer

2019-02-21 09:30:02 | Why Is Accuray ARAY Up 17% Since Last Earnings Report?

2019-02-20 16:06:00 | Cutera Appoints Katherine Zanotti and Joseph Whitters to its Board of Directors

2019-02-12 09:48:02 | Here's Why Investors Should Retain Accuray ARAY Stock Now

2019-02-06 10:33:15 | When Should You Buy Accuray Incorporated NASDAQ:ARAY?

2019-02-01 08:00:00 | Factors of Influence in 2019, Key Indicators and Opportunity within Marathon Oil, Accuray, United Natural Foods, Systemax, Amgen, and NewLink Genetics — New Research Emphasizes Economic Growth

2019-01-30 09:02:02 | Varian Strong on Global Expansion and Proton Therapy Arm

2019-01-29 10:32:03 | Accuray & China Isotope Collaborate to Sell Radiation Devices

2019-01-28 06:18:56 | BRIEF-Accuray And China Isotope And Radiation Corp Enter Joint Venture Contract

2019-01-28 06:00:00 | Accuray And China Isotope And Radiation Corporation Enter Joint Venture Contract To Manufacture And Sell Radiation Oncology Systems In China

2019-01-23 17:07:16 | 2 Stocks Jump on Wednesday

2019-01-23 16:32:00 | Why Accuray, Synchrony Financial, and Waters Jumped Today

2019-01-23 10:58:00 | Here's Why Accuray Is Flying Higher Today

2019-01-23 09:09:02 | Accuray's ARAY Q2 Loss Narrows, Radixact Demand Shoots Up

2019-01-23 00:16:18 | Accuray Inc ARAY Q2 2019 Earnings Conference Call Transcript

2019-01-23 00:13:21 | Edited Transcript of ARAY earnings conference call or presentation 22-Jan-19 9:30pm GMT

2019-01-22 16:22:38 | Accuray: Fiscal 2Q Earnings Snapshot

2019-01-22 16:05:00 | Accuray Reports Fiscal 2019 Second Quarter Results

2019-01-18 21:15:00 | Better Buy: Intuitive Surgical vs. Accuray

2019-01-17 07:30:00 | The Urology Group Surpasses 1,600 Prostate Cancer Patients Treated with the Accuray CyberKnife® M6™ System

2019-01-15 10:30:03 | Will Accuray ARAY Report Negative Earnings Next Week? What You Should Know

2019-01-08 07:30:00 | Accuray To Report Fiscal 2019 Second Quarter Financial Results on January 22, 2019

2019-01-07 08:50:56 | Read This Before Buying Accuray Incorporated NASDAQ:ARAY Shares

2019-01-02 07:30:00 | Accuray to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 9, 2019

2018-12-18 01:37:11 | Hedge Funds Are Betting On Accuray Incorporated ARAY

2018-12-06 07:30:00 | Accuray CyberKnife® System Treatment Delivery Times Up to 50 Percent Faster With Software Upgrade

2018-12-05 08:18:27 | How Should Investors React To Accuray Incorporated’s NASDAQ:ARAY CEO Pay?

2018-12-04 09:33:02 | Here's Why You Should Invest in Accuray ARAY Stock Now

2018-11-19 16:15:00 | Accuray Appoints Shig Hamamatsu Chief Financial Officer

2018-11-19 08:14:01 | Are WMGI & ARAY Neck and Neck? Let's Take a Closer Look

2018-11-12 07:35:00 | Research Report Identifies Ironwood Pharmaceuticals, The AES, Accuray, Ball, Park Hotels & Resorts, and NeoGenomics with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-11-06 18:15:05 | Accuray Inc ARAY President & CEO Joshua Levine Bought $118,750 of Shares

2018-11-01 09:32:01 | Accuray ARAY Q1 Loss Wider Than Expected, Gross Orders Rise

2018-10-31 15:01:00 | Accuray Incorporated ARAY Q1 2019 Earnings Conference Call Transcript

2018-10-31 02:19:24 | Edited Transcript of ARAY earnings conference call or presentation 30-Oct-18 8:30pm GMT

2018-10-30 19:00:11 | Accuray ARAY Reports Q1 Loss, Tops Revenue Estimates

2018-10-30 17:55:36 | Accuray: Fiscal 1Q Earnings Snapshot

2018-10-30 16:05:00 | Accuray Reports Fiscal 2019 First Quarter Financial Results

2018-10-18 08:45:00 | Factors of Influence in 2018, Key Indicators and Opportunity within Basic Energy Services, Scientific Games, The Michaels Companies, Accuray, Shake Shack, and NII — New Research Emphasizes Economic Growth

2018-10-17 14:29:32 | Who Are The Major Shareholders In Accuray Incorporated NASDAQ:ARAY?

2018-10-17 07:30:00 | Accuray Showcases Radiation Therapy Innovations Designed to Improve What's Possible for Patients at ASTRO 2018